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Background: Fundamental echocardiography has some drawbacks in patients with difficult-to-image echocardiograms. The 
aim of this study is to evaluate impact of contrast echocardiography (CE) on ventricular function assessment and clinical diagnosis 
in routine clinical echocardiography.
Methods: Two hundred sixty patients were prospectively enrolled over 3 years in 12 medical centers in Korea. General image 
quality, the number of distinguishable segments, ability to assess regional wall motion, left ventricular (LV) apex and right ven-
tricle (RV) visualization, LV ejection fraction, changes in diagnostic or treatment plan were documented after echocardiography 
with and without ultrasound contrast agent.
Results: Poor or uninterpretable general image was 31% before contrast use, and decreased to 2% (p < 0.05) after contrast use. 
The average number of visualized LV segments was 9.53 before contrast use, and increased to 14.46 (p < 0.001) after contrast use. 
The percentage of poor or not seen LV regional wall motion was decreased from 28.4% to 3.5% (p < 0.001). The percentage of 
poor or not seen LV apex and RV was decreased from 49.4% to 2.4% (p < 0.001), from 30.5% to 10.5% (p < 0.001), respectively. 
Changes in diagnostic procedure and treatment plan after CE were 30% and 29.6%, respectively.
Conclusion: Compared to fundamental echocardiography, CE impacted LV function assessment and clinical decision making 
in Korean patients who undergo routine echocardiography.
KEY WORDS: Contrast echocardiography · Multicenter study · Koreans.
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Introduction
Echocardiography has become an integral diagnostic tool in 
a clinical field of cardiology.1) Progress of acoustic and digital 
image processing technology has made echocardiography 
readily available, convenient, inexpensive, and time-saving di-
agnostic modality, whereas inherent disadvantages of cardiac 
ultrasound still exist.2-4) Endocardial border delineation (EBD) 
is important to evaluate left ventricular (LV) volume and ejec-
tion fraction (EF). Especially patients with obesity, lung disease, 
mechanical ventilation, surgical drains and tubes may have a 
poor echo window.5-8) LV volume and EF were consistently un-
derestimated by baseline echocardiography than cardiac mag-
netic resonance image.9)10) Low level of confidence with subop-
timal echocardiography leads to repetitive test or other types of 
diagnostic examination, causing increased patient’s medical cost 
and healthcare system burden.11-13) About 15% of routine echo-
cardiogram and up to 30% of echocardiogram in critically ill 
patients are suboptimal.14) Highly subjective and examiner de-
pendent feature is another pitfalls of echocardiogram without 
contrast. Inter-observer and intra-observer variability of non-
contrast echocardiography (CE) have been under criticism.
CE uses high molecular weight microbubble enclosed by 
lipids, albumin, or surfactant.15)16) Very low mechanical index 
(MI) ultrasound has enabled more pronounced nonlinear echo 
signal from microbubble while suppressing linear echo signal 
from myocardium.15)16) Clear left ventricular opacification (LVO) 
and EBD can be acquired by using ultrasound contrast agents 
(UCAs) in patients with poor image on harmonic echocardiog-
raphy. CE boasts 95% of EBD and conversion of 75% of pre-
viously non-diagnostic, poor echo results to interpretable ones.17) 
Trainee or novice in echo labs get the benefit more than expert 
from CE in not-echo-friendly circumstance as intensive care 
unit (ICU).18)19) Impact of CE on clinical decision making was 
reported in US20) and impact of CE in ICU patients also report-
ed in Korea.21) We examined impact of CE on assessment of LV 
function and diagnosis in routine clinical echocardiography in 
Korea.
Methods
Patient selection
From March, 2008 to March, 2011, 260 patients were pro-
spectively enrolled at 12 Korean teaching hospitals. Following 
routine rest echocardiography, discretionary CE was performed 
on same patients. The study was approved by Institutional Re-
view Committees at each hospital. A total of 12 expert physicians 
were involved in care of patients who enrolled. Myocardial CE 
and stress echocardiography were excluded.
Echocardiography protocols with and without 
contrast
Two-dimensional and spectral Doppler echocardiography 
were recorded from apical and parasternal windows. Second 
harmonic imaging and high MI (1.0 to 1.5) were used to ac-
quire echocardiography without contrast. When routine echo-
cardiogram was deemed suboptimal to interpret, Definity (Lan-
theus Medical Imaging, North Billerica, MA, USA) or SonoVue 
(Bracco Diagnostics, Milan, Italy) were delivered by bolus in-
jection or by continuous infusion and MI was adjusted to low 
level (0.3 to 0.5). Both images were stored digitally and inter-
preted within several hours.
Investigation of echocardiogram
Two independent observers participated. Conventional echo-
cardiography was interpreted by one observer and then CE im-
age was interpreted by the same observer. Another observer eval-
uated full echocardiographic results with and without contrast 
at once. Target variables were: global image quality, visualized 
LV segments, LV apex, LV EF, right ventricle (RV). Semi-quan-
titative grading was used to categorical variables.
Evaluation of the clinical impact
After baseline echocardiography is done, attending physician 
was contacted and has answered further diagnostic and man-
agement plan. CE result was exposed to the same physician, and 
he or she was questioned about possible changes of diagnostic 
and treatment plan.
Assessment of safety
Within 24 h after UCAs injection, any of all following: death, 
cardiac arrest, myocardial infarction, arrhythmia requiring im-
mediate intervention, anaphylactoid reaction, or hypotension 
were regarded safety end points.
Statistical analysis
SPSS for Windows (version 12.0; SSPS Inc., Chicago, IL, USA) 
was used for statistical analysis. Study population statistics 
were presented as mean ± SD for continuous variables and count 
percentages for categorical variables. McNemar test was used 
to reveal significant proportional differences between two groups. 
Wilcoxon signed rank test was used to compare the number of 
visualized LV segments before and after contrast. A p value of 
0.05 or lower was considered to be statistically significant.
Results
Patients and echocardiography characteristics
A total of 260 patients with routine or portable echocardiog-
raphy who underwent CE were enrolled. Baseline patient char-
acteristics are listed in Table 1. Mean age was 63.2 ± 15.1, male 
patients were 57.7%, cardiology patients were 66.5%, outpa-
tients were 16.9%, and patients in any kinds of ICU were 32.4%. 
Table 2 shows baseline echocardiographic characteristics. Rou-
tine echocardiography was 80.8% of all test, portable echocar-
diography was remaining 19.2%. Patients with mechanical 
ventilator were 13.8%. Echocardiography vendors were Acuson 
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(43.8%), GE (33.5%), and Philips (22.7%). UCAs used in study 
were mostly Definity (97.3%). Microbubble contrast was bolus 
injected (61.2%) or continuously infused (38.8%). Heart failure 
(31.2%) and coronary artery disease (45.8%) were main reasons 
for echocardiography (Table 3).
Benefits of CE
General image quality was classified under four headings; ad-
equate (full endocardial visualization), fair (greater than 50% 
visualized endocardium), poor (minimal endocardial visualiza-
tion), or uninterpretable (only epicardium visualized). Before 
contrast delivery, poor or uninterpretable echocardiography 
comprised 31% which decreased to 2% after contrast delivery 
(Fig. 1). The number of visualized LV segments per person was 
9.53 before contrast, which increased significantly to 14.46 af-
ter contrast (p < 0.001). The percentages of inadequate assess-
ment of LV wall motion, before and after contrast, were 28.4% 
and 3.5%, respectively (p < 0.001). LV apex delineation was 
also greatly increased by contrast. Baseline echocardiography 
has resulted in 49.4% of unsatisfactory echo views to rule out 
LV thrombus confidently. CE revealed LV apex more clearly, 
only 2.4% of all subject was ambiguous (Fig. 2). In patients 
whose LV EF was calculated, CE made a small but significant 
increase of EF; from 48.38% to 49.62% (p < 0.05). The per-
centage of poor or not seen RV from apical view were 30.5% 
without contrast, 10.5% with contrast (p < 0.001).
Clinical impact of CE
CE influenced clinical diagnostic and drug management plan. 
Table 1. Baseline patient characteristics
Characteristics n = 260
Age (yrs) 63.2 ± 15.1
Body surface area (m2) 1.65 ± 0.20
Male, n (%) 150 (57.7)
Blood pressure (mm Hg)
Systolic 124 ± 220
Diastolic 64 ± 13
Heart rate (beats/min) 80 ± 19
Patient type, n (%)
Cardiology 173 (66.5)
Noncardiology 087 (33.5)
Patient location, n (%)
Outpatient 044 (16.9)
CCU 034 (13.1)
MICU 015 (5.8)0
SICU 035 (13.5)
Ward 132 (50.7)
CCU: cardiac care unit, MICU: medical intensive care unit, SICU: surgical 
intensive care unit
Table 2. Baseline echocardiographic characteristics
Contrast echocardiography n = 260
Type of echo, n (%)
Routine 210 (80.8)
Portable 50 (19.2)
Ventilator care, n (%) 36 (13.8)
Machine type, n (%)
Phillips 59 (22.7)
Acuson 114 (43.8)
GE 87 (33.5)
Contrast agents, n (%)
Definity 253 (97.3)
Sonovue 5 (1.9)0
PESDA 2 (0.8)0
Injection protocol, n (%)
Single bolus 159 (61.2)
Infusion 101 (38.8)
Machine setting, n (%)
LVO default 244 (93.8)
2-dimensional or manual 16 (6.2)0
LVO: left ventricular opacification, PESDA: perfluorocarbon-exposed soni-
cated dextrose albumin
Table 3. Indications for contrast echocardiography
Clinical indications n = 260
Heart failure, n (%) 81 (31.2)
ECG abnormality, n (%) 27 (10.4)
Valvular heart disease, n (%) 7 (2.7)0
CAD evaluation, n (%) 119 (45.8)
Preoperative evaluation, n (%) 18 (6.9)0
Stroke, n (%) 8 (3.1)0
ECG: electrocardiogram, CAD: coronary artery disease
Fig. 1. Effect of contrast echocardiography on general image quality. 
Image quality was significantly improved after contrast use (McNemar’s 
test, p < 0.05).
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Thirty percent of all CE result has made changes of further di-
agnostic procedure (i.e., cancelling nuclear imaging, transesoph-
ageal echocardiography, or diagnostic angiography). Treatment 
plan was also changed by physicians after CE review, 29.6% of 
all subjects (Fig. 3).
Safety profile of contrast use
Among 260 patients, no adverse reaction including back 
pain, renal pain, chest pain, headache, dizziness, flushing, nau-
sea, vomiting, or others was reported within 24 h after UCAs 
injection.
discussion
This Korean multicenter study showed that CE augmented 
general image quality, confidence, global and regional LV func-
tion assessment, RV image quality and influenced physician’s 
diagnostic and management plan. Suboptimal echo images 
with routine and portable echocardiography necessitate other 
expensive medical modalities.2-4) CE-LVO produces clearer 
EBD than fundamental echocardiography, especially in pa-
tients with obesity, chronic obstructive lung disease, altered 
mentality who are difficult to image.1)22-24) Commercially avail-
able contrasts have prolonged time span of opacification and 
high blood to myocardium signal ratio.25) UCAs are hemody-
namically inert and have a same rheology as blood cells.26)27) In 
addition, CE is useful in stress echocardiography,28) LV throm-
bus or mass detection,29) RV and great vessel examination,30)31) 
mitral regurgitation and aortic stenosis grading.32)33)
Large multicenter prospective clinical trial in US was report-
ed in 2009 by Kurt et al.20) A total of 632 patients with tech-
nically difficult images were enrolled. Baseline patient charac-
teristics in US study and in this Korean study are almost same 
except mean body surface area (BSA). An average BSA in US 
study was 2.09 m2, whereas an average BSA in Korean study 
was 1.65 m2. In general image quality, 11.7% of patients were 
uninterpretable in US study, but 2.8% of patients were unin-
terpretable in Korean study. This disparity is a possible conse-
quence of higher body mass or BSA in US patients. Echo win-
dows in Korean patients are slightly better than in US patients. 
CE revealed more endocardial segments assessment than fun-
damental echocardiography consistently in both studies; 5.3 
more visualized segments after contrast in US, 4.9 more visu-
alized segments after contrast in Korea.
Cohen et al.17) reported superiority of CE for LV EBD in 203 
patients with suboptimal echo images in a US prospective mul-
ticenter trial. Kitzman et al.22) showed improvement of EBD 
with CE in 211 patients with suspected cardiac disease and 
suboptimal fundamental echocardiograms in a US multicenter 
study. In a European multicenter trial, 100 patients planned for 
routine coronary angiography with or without heart failure were 
enrolled.34) CE increased inter-observer agreement of regional 
wall motion. A total of 218 patients with suspected coronary 
heart disease were enrolled in a European multicenter study by 
Senior et al.35) CE was safe and effective for LV EBD. Hwang et 
al.21) reported impact of contrast agent on assessment of LV func-
tion and on clinical diagnosis in a Korean prospective multi-
center trial on ICU patients. Our study included not only selec-
tive population enrolled by previous studies but also routine 
clinical population. Therefore, this study might reflect well ben-
efit of CE in real clinical practice.
This study has some limitations. First, cost-effectiveness of 
CE was not fully and specifically calculated with health insur-
ance reimbursement data. Second, the study was not fully blind-
ed by physicians and sonographers. Pre-expectation of observ-
ers may cause biased results. Automated assessment function 
by vendors was not used in EF estimation or wall motion anal-
ysis to reduce human errors. Third, readers, observers, and cardi-
ologists in 12 teaching hospitals did not have same exact echo-
cardiographic measurement technique, experience in cardiac 
echo labs, clinical decision making standards. Lastly, relatively 
small sample size.
However, this study is a first Korean multicenter study that in-
vestigated the utility of CE in a routine clinical echocardiogra-
phy. And it showed CE was still useful despite Korean patients 
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Fig. 2. Effect of contrast echocardiography on left ventricular (LV) apex 
visualization. LV apex was revealed clearly after contrast use (p < 0.001).
Fig. 3. Impact of contrast echocardiography on treatment plan. Twenty- 
nine point six percent of subjects with contrast echocardiography have 
changed treatment plan.
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had relatively low BSA. Also, this study suggested the efficacy 
of CE in real routine clinical world because study population 
included not only patients in ICU or with poor echo window 
but also patients in routine clinical echocardiography environ-
ment.
In conclusion, regarding routine clinical echocardiography in 
Korean population, CE in comparison with fundamental echo-
cardiography improved LV function assessment and clinical 
decision making.
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